The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics
Current evidence on the roles of the immune microenvironment and individual heterogeneity in shaping the pathogenesis and treatment landscape of Myasthenia gravis is discussed, emphasizing the transition from phenotype-based disease classification toward immune endotype-driven precision medicine within population heter...